Skip to main content
Loading

The most efficient route to antibodies with real functional activity vs. binders.

28 Oct 2024
Lead Identification & Optimization
  • Functional screening vs binding assays.
  • Engineering antibodies to enhance Fc-region-mediated effector functions.
  • Combining In silico and in vivo models.
Industry Experts
Jean-Philippe Fortin, Senior Scientific Director, Head of Pharmacology - Pfizer